nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CALM1—autonomic nervous system—conduct disorder	0.042	0.251	CbGeAlD
Nicardipine—PDE1B—brain—conduct disorder	0.0124	0.0743	CbGeAlD
Nicardipine—PDE1A—brain—conduct disorder	0.0104	0.0623	CbGeAlD
Nicardipine—CHRM4—brain—conduct disorder	0.00953	0.057	CbGeAlD
Nicardipine—CACNB2—brain—conduct disorder	0.00769	0.0459	CbGeAlD
Nicardipine—CHRM5—brain—conduct disorder	0.00745	0.0445	CbGeAlD
Nicardipine—CACNA2D1—brain—conduct disorder	0.00722	0.0431	CbGeAlD
Nicardipine—ADRA1B—brain—conduct disorder	0.00681	0.0407	CbGeAlD
Nicardipine—CACNA1D—brain—conduct disorder	0.00672	0.0401	CbGeAlD
Nicardipine—ADRA1D—brain—conduct disorder	0.00666	0.0398	CbGeAlD
Nicardipine—CACNA1C—brain—conduct disorder	0.0062	0.0371	CbGeAlD
Nicardipine—CALM3—brain—conduct disorder	0.00519	0.031	CbGeAlD
Nicardipine—CHRM2—brain—conduct disorder	0.00512	0.0306	CbGeAlD
Nicardipine—CHRM1—brain—conduct disorder	0.00466	0.0278	CbGeAlD
Nicardipine—CHRM3—brain—conduct disorder	0.00417	0.0249	CbGeAlD
Nicardipine—CALM2—brain—conduct disorder	0.00408	0.0244	CbGeAlD
Nicardipine—CALM1—brain—conduct disorder	0.00406	0.0243	CbGeAlD
Nicardipine—ADRA1A—brain—conduct disorder	0.00383	0.0229	CbGeAlD
Nicardipine—CYP2C8—brain—conduct disorder	0.00338	0.0202	CbGeAlD
Nicardipine—CYP2B6—brain—conduct disorder	0.00303	0.0181	CbGeAlD
Nicardipine—CYP2E1—brain—conduct disorder	0.00285	0.017	CbGeAlD
Nicardipine—CYP2D6—brain—conduct disorder	0.00225	0.0135	CbGeAlD
Nicardipine—ABCB1—brain—conduct disorder	0.00162	0.00968	CbGeAlD
Nicardipine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.0011	0.00132	CbGpPWpGaD
Nicardipine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0011	0.00132	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.0011	0.00132	CbGpPWpGaD
Nicardipine—CALM3—Neuronal System—COMT—conduct disorder	0.00108	0.0013	CbGpPWpGaD
Nicardipine—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	0.00108	0.0013	CbGpPWpGaD
Nicardipine—CALM3—Neuronal System—MAOA—conduct disorder	0.00107	0.00129	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—WASF1—conduct disorder	0.00107	0.00129	CbGpPWpGaD
Nicardipine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00106	0.00127	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00105	0.00126	CbGpPWpGaD
Nicardipine—CALM1—Neuronal System—COMT—conduct disorder	0.00105	0.00126	CbGpPWpGaD
Nicardipine—CALM2—Neuronal System—COMT—conduct disorder	0.00105	0.00126	CbGpPWpGaD
Nicardipine—CALM2—Neuronal System—MAOA—conduct disorder	0.00104	0.00125	CbGpPWpGaD
Nicardipine—CALM1—Neuronal System—MAOA—conduct disorder	0.00104	0.00125	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—WASF1—conduct disorder	0.00104	0.00125	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—WASF1—conduct disorder	0.00104	0.00125	CbGpPWpGaD
Nicardipine—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	0.00103	0.00124	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00102	0.00123	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.00102	0.00123	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—WASF1—conduct disorder	0.00102	0.00122	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MB21D1—conduct disorder	0.00101	0.00122	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00101	0.00121	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00101	0.00121	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MB21D1—conduct disorder	0.000979	0.00118	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MB21D1—conduct disorder	0.000979	0.00118	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.000973	0.00117	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000959	0.00115	CbGpPWpGaD
Nicardipine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000957	0.00115	CbGpPWpGaD
Nicardipine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000954	0.00115	CbGpPWpGaD
Nicardipine—PDE1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000948	0.00114	CbGpPWpGaD
Nicardipine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000945	0.00113	CbGpPWpGaD
Nicardipine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000942	0.00113	CbGpPWpGaD
Nicardipine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	0.000936	0.00112	CbGpPWpGaD
Nicardipine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000916	0.0011	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CGA—conduct disorder	0.000897	0.00108	CbGpPWpGaD
Nicardipine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	0.000896	0.00108	CbGpPWpGaD
Nicardipine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000873	0.00105	CbGpPWpGaD
Nicardipine—PDE1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000867	0.00104	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by GPCR—HTR2A—conduct disorder	0.000861	0.00103	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CGA—conduct disorder	0.000859	0.00103	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CGA—conduct disorder	0.000854	0.00103	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	0.00085	0.00102	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.000843	0.00101	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CGA—conduct disorder	0.000826	0.000992	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CGA—conduct disorder	0.000826	0.000992	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	0.000814	0.000978	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000808	0.00097	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.000807	0.00097	CbGpPWpGaD
Nicardipine—CACNB2—Developmental Biology—EP300—conduct disorder	0.000801	0.000962	CbGpPWpGaD
Nicardipine—PDE1A—Hemostasis—EP300—conduct disorder	0.000794	0.000954	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by GPCR—HTR2A—conduct disorder	0.000787	0.000945	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—DRD4—conduct disorder	0.000779	0.000936	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.000765	0.000919	CbGpPWpGaD
Nicardipine—CACNA1D—Developmental Biology—EP300—conduct disorder	0.000758	0.000911	CbGpPWpGaD
Nicardipine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000744	0.000893	CbGpPWpGaD
Nicardipine—CALM3—Immune System—POLR3A—conduct disorder	0.000743	0.000892	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—COMT—conduct disorder	0.000743	0.000892	CbGpPWpGaD
Nicardipine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000738	0.000887	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—MAOA—conduct disorder	0.000737	0.000886	CbGpPWpGaD
Nicardipine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000733	0.000881	CbGpPWpGaD
Nicardipine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.000729	0.000875	CbGpPWpGaD
Nicardipine—PDE1B—Hemostasis—EP300—conduct disorder	0.000727	0.000873	CbGpPWpGaD
Nicardipine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	0.000726	0.000872	CbGpPWpGaD
Nicardipine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.000722	0.000868	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—CGA—conduct disorder	0.000721	0.000866	CbGpPWpGaD
Nicardipine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.000719	0.000864	CbGpPWpGaD
Nicardipine—CALM2—Immune System—POLR3A—conduct disorder	0.000719	0.000863	CbGpPWpGaD
Nicardipine—CALM1—Immune System—POLR3A—conduct disorder	0.000719	0.000863	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—WASF1—conduct disorder	0.000719	0.000863	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000717	0.000861	CbGpPWpGaD
Nicardipine—PDE1A—Innate Immune System—EP300—conduct disorder	0.000715	0.000859	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—DRD4—conduct disorder	0.000713	0.000856	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—COMT—conduct disorder	0.000703	0.000845	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.000699	0.00084	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—MAOA—conduct disorder	0.000698	0.000839	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—WASF1—conduct disorder	0.000688	0.000826	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.00067	0.000805	CbGpPWpGaD
Nicardipine—CACNA1C—Developmental Biology—EP300—conduct disorder	0.000666	0.0008	CbGpPWpGaD
Nicardipine—PDE1B—Innate Immune System—EP300—conduct disorder	0.000654	0.000786	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.000647	0.000777	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.000635	0.000763	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.000631	0.000758	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	0.000629	0.000756	CbGpPWpGaD
Nicardipine—CALM3—Immune System—WASF1—conduct disorder	0.000625	0.000751	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.000623	0.000748	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000621	0.000746	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—CGA—conduct disorder	0.00062	0.000745	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—COMT—conduct disorder	0.000618	0.000742	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—MAOA—conduct disorder	0.000614	0.000737	CbGpPWpGaD
Nicardipine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	0.000611	0.000733	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—CGA—conduct disorder	0.000607	0.000729	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—CGA—conduct disorder	0.000606	0.000728	CbGpPWpGaD
Nicardipine—CALM2—Immune System—WASF1—conduct disorder	0.000605	0.000727	CbGpPWpGaD
Nicardipine—CALM1—Immune System—WASF1—conduct disorder	0.000605	0.000727	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CGA—conduct disorder	0.000605	0.000726	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—CGA—conduct disorder	0.000603	0.000725	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CGA—conduct disorder	0.000603	0.000724	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CGA—conduct disorder	0.000597	0.000717	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.000595	0.000715	CbGpPWpGaD
Nicardipine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	0.000585	0.000702	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—CGA—conduct disorder	0.000584	0.000701	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—CGA—conduct disorder	0.000584	0.000701	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	0.000573	0.000688	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	0.000571	0.000686	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.000566	0.000679	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.000564	0.000678	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	0.000555	0.000666	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.00055	0.00066	CbGpPWpGaD
Nicardipine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000547	0.000657	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.000537	0.000645	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	0.000531	0.000638	CbGpPWpGaD
Nicardipine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000529	0.000636	CbGpPWpGaD
Nicardipine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000529	0.000636	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—CGA—conduct disorder	0.000525	0.00063	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—HTR2A—conduct disorder	0.000508	0.000611	CbGpPWpGaD
Nicardipine—CALM3—Signaling by WNT in cancer—EP300—conduct disorder	0.000508	0.00061	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CGA—conduct disorder	0.000505	0.000606	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—DRD4—conduct disorder	0.000502	0.000603	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.000499	0.0006	CbGpPWpGaD
Nicardipine—CALM2—Signaling by WNT in cancer—EP300—conduct disorder	0.000491	0.00059	CbGpPWpGaD
Nicardipine—CALM1—Signaling by WNT in cancer—EP300—conduct disorder	0.000491	0.00059	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CGA—conduct disorder	0.000488	0.000586	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CGA—conduct disorder	0.000488	0.000586	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—WASF1—conduct disorder	0.000484	0.000582	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—WASF1—conduct disorder	0.000483	0.00058	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—DRD4—conduct disorder	0.000481	0.000577	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—DRD4—conduct disorder	0.000478	0.000574	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.000478	0.000574	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000477	0.000573	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000476	0.000572	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CGA—conduct disorder	0.000469	0.000563	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—HTR2A—conduct disorder	0.000465	0.000558	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—DRD4—conduct disorder	0.000463	0.000556	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—DRD4—conduct disorder	0.000463	0.000556	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CGA—conduct disorder	0.000457	0.000549	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000456	0.000548	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.000452	0.000543	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CGA—conduct disorder	0.000431	0.000518	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CGA—conduct disorder	0.000427	0.000513	CbGpPWpGaD
Nicardipine—CALM3—Signaling by Wnt—EP300—conduct disorder	0.000419	0.000503	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—EP300—conduct disorder	0.000417	0.0005	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.000414	0.000498	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.000412	0.000495	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	0.00041	0.000493	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.000406	0.000488	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000405	0.000487	CbGpPWpGaD
Nicardipine—CALM1—Signaling by Wnt—EP300—conduct disorder	0.000405	0.000487	CbGpPWpGaD
Nicardipine—CALM2—Signaling by Wnt—EP300—conduct disorder	0.000405	0.000487	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—WASF1—conduct disorder	0.000404	0.000486	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—WASF1—conduct disorder	0.000391	0.00047	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—WASF1—conduct disorder	0.000391	0.00047	CbGpPWpGaD
Nicardipine—PDE1A—Disease—EP300—conduct disorder	0.000385	0.000462	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—EP300—conduct disorder	0.000381	0.000458	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000375	0.000451	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	0.000374	0.000449	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	0.000373	0.000448	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.000369	0.000443	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000368	0.000442	CbGpPWpGaD
Nicardipine—PDE1B—Disease—EP300—conduct disorder	0.000352	0.000422	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—DRD4—conduct disorder	0.000339	0.000407	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—DRD4—conduct disorder	0.000337	0.000405	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.000334	0.000401	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000333	0.0004	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	0.000328	0.000393	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—COMT—conduct disorder	0.000325	0.000391	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—MAOA—conduct disorder	0.000323	0.000388	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—EP300—conduct disorder	0.000318	0.000383	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	0.000314	0.000377	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HTR2A—conduct disorder	0.000312	0.000375	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HTR2A—conduct disorder	0.000302	0.000363	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HTR2A—conduct disorder	0.000302	0.000363	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—EP300—conduct disorder	0.000302	0.000362	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000295	0.000354	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—EP300—conduct disorder	0.000288	0.000346	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—DRD4—conduct disorder	0.000283	0.000339	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CGA—conduct disorder	0.000282	0.000338	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—COMT—conduct disorder	0.00028	0.000336	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—EP300—conduct disorder	0.000279	0.000335	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—EP300—conduct disorder	0.000279	0.000335	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—MAOA—conduct disorder	0.000278	0.000334	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—COMT—conduct disorder	0.000274	0.000329	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—COMT—conduct disorder	0.000274	0.000329	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—DRD4—conduct disorder	0.000273	0.000328	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—DRD4—conduct disorder	0.000273	0.000328	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—COMT—conduct disorder	0.000272	0.000327	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—MAOA—conduct disorder	0.000272	0.000327	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—MAOA—conduct disorder	0.000272	0.000326	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—MAOA—conduct disorder	0.00027	0.000325	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—EP300—conduct disorder	0.000269	0.000323	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—EP300—conduct disorder	0.000265	0.000318	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—COMT—conduct disorder	0.000263	0.000316	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—COMT—conduct disorder	0.000263	0.000316	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—MAOA—conduct disorder	0.000262	0.000314	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—MAOA—conduct disorder	0.000262	0.000314	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—EP300—conduct disorder	0.000259	0.000311	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—EP300—conduct disorder	0.000251	0.000301	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—EP300—conduct disorder	0.000251	0.000301	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—EP300—conduct disorder	0.000246	0.000296	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000245	0.000294	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—COMT—conduct disorder	0.000237	0.000285	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—MAOA—conduct disorder	0.000235	0.000283	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000228	0.000274	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	0.000221	0.000265	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	0.00022	0.000264	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000218	0.000262	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000217	0.000261	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—COMT—conduct disorder	0.000211	0.000254	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—MAOA—conduct disorder	0.00021	0.000252	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—COMT—conduct disorder	0.000206	0.000248	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—MAOA—conduct disorder	0.000205	0.000246	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000204	0.000245	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—COMT—conduct disorder	0.000195	0.000234	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—MAOA—conduct disorder	0.000193	0.000232	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—COMT—conduct disorder	0.000193	0.000232	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—MAOA—conduct disorder	0.000191	0.00023	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000186	0.000223	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HTR2A—conduct disorder	0.000184	0.000221	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HTR2A—conduct disorder	0.000178	0.000214	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HTR2A—conduct disorder	0.000178	0.000214	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EP300—conduct disorder	0.000174	0.000208	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EP300—conduct disorder	0.000166	0.0002	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000156	0.000188	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EP300—conduct disorder	0.000151	0.000181	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EP300—conduct disorder	0.000146	0.000176	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EP300—conduct disorder	0.000146	0.000176	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—EP300—conduct disorder	0.00014	0.000168	CbGpPWpGaD
Nicardipine—CALM3—Disease—EP300—conduct disorder	0.000139	0.000168	CbGpPWpGaD
Nicardipine—CALM1—Disease—EP300—conduct disorder	0.000135	0.000162	CbGpPWpGaD
Nicardipine—CALM2—Disease—EP300—conduct disorder	0.000135	0.000162	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.00013	0.000156	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—COMT—conduct disorder	0.000127	0.000153	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000126	0.000152	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—EP300—conduct disorder	0.00012	0.000144	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—EP300—conduct disorder	0.000118	0.000141	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—EP300—conduct disorder	0.000117	0.000141	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EP300—conduct disorder	0.000117	0.000141	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—EP300—conduct disorder	0.000117	0.00014	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EP300—conduct disorder	0.000117	0.00014	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000116	0.000139	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.000115	0.000138	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—EP300—conduct disorder	0.000113	0.000136	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—EP300—conduct disorder	0.000113	0.000136	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—EP300—conduct disorder	0.000102	0.000122	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EP300—conduct disorder	9.77e-05	0.000117	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EP300—conduct disorder	9.45e-05	0.000113	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EP300—conduct disorder	9.45e-05	0.000113	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—EP300—conduct disorder	9.07e-05	0.000109	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—EP300—conduct disorder	8.85e-05	0.000106	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—EP300—conduct disorder	8.34e-05	0.0001	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—EP300—conduct disorder	8.27e-05	9.93e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—EP300—conduct disorder	5.45e-05	6.55e-05	CbGpPWpGaD
